标题
Alternative mRNA Splicing and Promising Therapies in Cancer
作者
关键词
-
出版物
Biomolecules
Volume 13, Issue 3, Pages 561
出版商
MDPI AG
发表日期
2023-03-20
DOI
10.3390/biom13030561
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Delivery of antisense oligonucleotides for splice‐correction of androgen receptor pre‐mRNA in castration‐resistant prostate cancer models using cell‐penetrating peptides
- (2022) Maria V. Luna Velez et al. PROSTATE
- Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers
- (2022) Yoshihisa Kobayashi et al. NATURE
- The complete sequence of a human genome
- (2022) Sergey Nurk et al. SCIENCE
- Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets
- (2022) Vincenza Barresi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PRMT5 inhibition disrupts splicing and stemness in glioblastoma
- (2021) Patty Sachamitr et al. Nature Communications
- The International Human Genome Project
- (2021) Ewan Birney HUMAN MOLECULAR GENETICS
- Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication
- (2021) Ting Cai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
- (2021) Wei Huang et al. Journal of Hematology & Oncology
- Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
- (2021) David P. Steensma et al. LEUKEMIA
- Impact of alternative splicing on mechanisms of resistance to anticancer drugs
- (2021) Maria Reviejo et al. BIOCHEMICAL PHARMACOLOGY
- ASO-based PKM splice-switching therapy inhibits hepatocellular carcinoma growth
- (2021) Wai Kit Ma et al. CANCER RESEARCH
- Aberrant RNA splicing and therapeutic opportunities in cancers
- (2021) Hirofumi Yamauchi et al. CANCER SCIENCE
- Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics
- (2021) Qiu Peng et al. MOLECULAR THERAPY
- The Interplay Between the DNA Damage Response, RNA Processing and Extracellular Vesicles
- (2020) Xiangbing Meng et al. Frontiers in Oncology
- Writers, readers and erasers of RNA modifications in cancer
- (2020) Rosaura Esteve-Puig et al. CANCER LETTERS
- Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer
- (2020) Dingxiao Zhang et al. Nature Communications
- The role of alternative splicing in cancer: From oncogenesis to drug resistance
- (2020) Rocco Sciarrillo et al. DRUG RESISTANCE UPDATES
- Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
- (2019) Eric Wang et al. CANCER CELL
- Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation
- (2019) Jia Yi Fong et al. CANCER CELL
- Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing
- (2019) Megan Stevens et al. Frontiers in Genetics
- RNA Splicing by the Spliceosome
- (2019) Max E. Wilkinson et al. Annual Review of Biochemistry
- Therapeutic approaches to treat human spliceosomal diseases
- (2019) Anthony B DeNicola et al. CURRENT OPINION IN BIOTECHNOLOGY
- Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy
- (2019) Xuesen Dong et al. ONCOGENE
- Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
- (2018) Rita Assi et al. CANCER
- Splicing dysregulation as a driver of breast cancer
- (2018) Abigail Read et al. ENDOCRINE-RELATED CANCER
- H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
- (2018) Michael Seiler et al. NATURE MEDICINE
- Nuclear retention of mRNAs – quality control, gene regulation and human disease
- (2018) Marius Wegener et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- hnRNP A1/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damage
- (2018) Alexandre Cloutier et al. Scientific Reports
- Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
- (2018) Laura M. Urbanski et al. Wiley Interdisciplinary Reviews-RNA
- Systematic evaluation of isoform function in literature reports of alternative splicing
- (2018) Shamsuddin A. Bhuiyan et al. BMC GENOMICS
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
- (2018) André Kahles et al. CANCER CELL
- Quantitative Activity Profile and Context Dependence of All Human 5′ Splice Sites
- (2018) Mandy S. Wong et al. MOLECULAR CELL
- RNA Polymerase II Phosphorylated on CTD Serine 5 Interacts with the Spliceosome during Co-transcriptional Splicing
- (2018) Takayuki Nojima et al. MOLECULAR CELL
- SR Proteins: Binders, Regulators, and Connectors of RNA
- (2017) Sunjoo Jeong MOLECULES AND CELLS
- Pathogenic variants that alter protein code often disrupt splicing
- (2017) Rachel Soemedi et al. NATURE GENETICS
- PRMT5 as a druggable target for glioblastoma therapy
- (2017) Yeshavanth Kumar Banasavadi-Siddegowda et al. NEURO-ONCOLOGY
- MODOMICS: a database of RNA modification pathways. 2017 update
- (2017) Pietro Boccaletto et al. NUCLEIC ACIDS RESEARCH
- Alternative Splicing May Not Be the Key to Proteome Complexity
- (2017) Michael L. Tress et al. TRENDS IN BIOCHEMICAL SCIENCES
- RNA splicing process analysis for identifying antisense oligonucleotide inhibitors with padlock probe-based isothermal amplification
- (2017) Xiaojun Ren et al. Chemical Science
- The Functional Impact of Alternative Splicing in Cancer
- (2017) Héctor Climente-González et al. Cell Reports
- Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability
- (2017) Brenton R Paolella et al. eLife
- The BRCA1- 11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin
- (2016) Y. Wang et al. CANCER RESEARCH
- The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non‐coding RNA and synonymous mutations
- (2016) Sven Diederichs et al. EMBO Molecular Medicine
- Coupling of RNA Polymerase II Transcription Elongation with Pre-mRNA Splicing
- (2016) Tassa Saldi et al. JOURNAL OF MOLECULAR BIOLOGY
- Therapeutic targeting of splicing in cancer
- (2016) Stanley Chun-Wei Lee et al. NATURE MEDICINE
- Splicing-factor alterations in cancers
- (2016) Olga Anczuków et al. RNA
- Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage
- (2016) Samar Alsafadi et al. Nature Communications
- Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms
- (2016) Charlotte K. Brierley et al. Current Hematologic Malignancy Reports
- SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
- (2015) Eunhee Kim et al. CANCER CELL
- MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis
- (2015) Cheryl M. Koh et al. NATURE
- A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
- (2015) Elayne Chan-Penebre et al. Nature Chemical Biology
- RNA mis-splicing in disease
- (2015) Marina M. Scotti et al. NATURE REVIEWS GENETICS
- An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth
- (2014) A. S. Adler et al. GENES & DEVELOPMENT
- PRPF8 defects cause missplicing in myeloid malignancies
- (2014) A Kurtovic-Kozaric et al. LEUKEMIA
- High antitumor activity of pladienolide B and its derivative in gastric cancer
- (2013) Momoko Sato et al. CANCER SCIENCE
- Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors
- (2013) F. A. L. M. Eskens et al. CLINICAL CANCER RESEARCH
- The spliceosome as a target of novel antitumour drugs
- (2012) Sophie Bonnal et al. NATURE REVIEWS DRUG DISCOVERY
- Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms
- (2012) S. Erkelenz et al. RNA
- Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing
- (2011) Liying Fan et al. ACS Chemical Biology
- Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A
- (2011) A. Corrionero et al. GENES & DEVELOPMENT
- Increased levels of noisy splicing in cancers, but not for oncogene-derived transcripts
- (2011) Lu Chen et al. HUMAN MOLECULAR GENETICS
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
- (2011) Víctor Quesada et al. NATURE GENETICS
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- (2011) Lili Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
- (2009) Charles J. David et al. NATURE
- The SR protein family of splicing factors: master regulators of gene expression
- (2008) Jennifer C. Long et al. BIOCHEMICAL JOURNAL
- The Biflavonoid Isoginkgetin Is a General Inhibitor of Pre-mRNA Splicing
- (2008) Kristine O'Brien et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel Splicing Factor RBM25 Modulates Bcl-x Pre-mRNA 5' Splice Site Selection
- (2008) A. Zhou et al. MOLECULAR AND CELLULAR BIOLOGY
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
- Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
- (2008) Qun Pan et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started